Introduction Semaglutide has emerged as a revolutionary medication in the realm of healthcare, targeting conditions like obesity, type 2 diabetes, and cardiovascular risks. Part of the GLP-1 receptor agonists family, Semaglutide mimics the hormone glucagon-like peptide-1 (GLP-1), which plays a pivotal role in regulating blood sugar, stimulating insulin release, and https://ukdirectoryof.com/listings13007329/semaglutide-a-revolutionary-treatment-for-diabetes-obesity-and-cardiovascular-health